BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29507277)

  • 1. Light Chain Deposition Disease Associated With Multiple Myeloma Developing in Late Pregnancy.
    Kim MJ; Kim JH; Kim IY; Lee SB; Park IS; Han MY; Rhee H; Song SH; Seong EY; Kwak IS; Lee DW
    Iran J Kidney Dis; 2018 Mar; 12(2):132-134. PubMed ID: 29507277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unravelling the immunopathological mechanisms of heavy chain deposition disease with implications for clinical management.
    Bridoux F; Javaugue V; Bender S; Leroy F; Aucouturier P; Debiais-Delpech C; Goujon JM; Quellard N; Bonaud A; Clavel M; Trouillas P; Di Meo F; Gombert JM; Fermand JP; Jaccard A; Cogné M; Touchard G; Sirac C
    Kidney Int; 2017 Feb; 91(2):423-434. PubMed ID: 27773425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystalline cast nephropathy in a patient with IgD lambda myeloma.
    Kumakura S; Nakaya I; Sakuma T; Sato H; Soma J
    Clin Exp Nephrol; 2016 Jun; 20(3):491-2. PubMed ID: 26515717
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution.
    Nasr SH; Valeri AM; Cornell LD; Fidler ME; Sethi S; D'Agati VD; Leung N
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):231-9. PubMed ID: 22156754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-free light chain analysis: works in progress.
    Merlini G
    Clin Chem Lab Med; 2009; 47(9):1021-2. PubMed ID: 19728842
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinicopathological significance of monoclonal IgA deposition in patients with IgA nephropathy.
    Nagae H; Tsuchimoto A; Tsuruya K; Kawahara S; Shimomura Y; Noguchi H; Masutani K; Katafuchi R; Kitazono T
    Clin Exp Nephrol; 2017 Apr; 21(2):266-274. PubMed ID: 27170372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological characteristics of light chain proximal tubulopathy in Korean patients and the diagnostic usefulness of immunohistochemical staining for immunoglobulin light chain.
    Jung M; Lee Y; Lee H; Moon KC
    BMC Nephrol; 2020 Apr; 21(1):146. PubMed ID: 32326898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of free kappa and lambda chains in serum and the significance of their ratio in patients with multiple myeloma.
    Nelson M; Brown RD; Gibson J; Joshua DE
    Br J Haematol; 1992 Jun; 81(2):223-30. PubMed ID: 1643019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A very unusual case of amyloidosis].
    Jouvin MH; Nochy D; Bruneval P; Guettier C; Druet P; Bariéty J
    Nephrologie; 1985; 6(3):159-62. PubMed ID: 3935940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma.
    Iványi B
    Arch Pathol Lab Med; 1990 Sep; 114(9):986-7. PubMed ID: 2117910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains.
    Jiwani S; Bornhost J; Alapat D
    Int J Clin Exp Pathol; 2015; 8(7):8536-44. PubMed ID: 26339430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Light chain myeloma or the pitfalls of myeloma diagnosis].
    Zufferey P; Pugin P; Regamey C
    Schweiz Med Wochenschr; 1989 Jun; 119(22):791-5. PubMed ID: 2503870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
    Singh G
    Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation.
    Larsen CP; Bell JM; Harris AA; Messias NC; Wang YH; Walker PD
    Mod Pathol; 2011 Nov; 24(11):1462-9. PubMed ID: 21701535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double Bence Jones proteinuria.
    Kanoh T; Yago K
    Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
    Noel LH; Droz D; Ganeval D; Grunfeld JP
    Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsecretory myeloma associated with nodular glomerulosclerosis.
    Sølling K; Sølling J; Jacobsen NO; Thomsen OF
    Acta Med Scand; 1980; 207(1-2):137-43. PubMed ID: 6768224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease.
    Niewmierzycka A; Kurman M; Leśniak M; Winiarska A; Pawłowska A
    Pol Arch Med Wewn; 2015; 125(7-8):532-7. PubMed ID: 26038841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic lambda light-chain deposition in a patient with myeloma.
    Ganeval D; Noël LH; Droz D; Leibowitch J
    Br Med J (Clin Res Ed); 1981 Feb; 282(6265):681-3. PubMed ID: 6781614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.